MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced the appointment of Matthew Peterson, Ph.D., as Senior Clinical ...

Binance Labs has made its first foray into the Decentralized Science (DeSci) sector with an investment in BIO Protocol (BIO), ...

Binance Labs backs BIO Protocol in a push to decentralize scientific research funding via blockchain, advancing global biotech innovation.

Binance Labs has invested in BIO Protocol, marking its first venture into decentralized science. BIO Protocol’s BioDAO ...

Allovir Inc., which has struggled since late last December, will merge with privately held Kalaris Therapeutics Inc. to develop therapies for treating neovascular and exudative retinal diseases.

BIO aims to use blockchain technology to change how early-stage scientific research is financed and commercialized.

SAN DIEGO (AP) — SAN DIEGO (AP) — Telesis Bio, Inc. (TBIO) on Thursday reported a loss of $6.6 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of ...

Avid Bioservices Inc., a Tustin-based biotech company, agreed to go private in an $850-million deal that values the company ...

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.45 per share a year ago. These figures are ...

Revenue from collaborative research was $6.8 million for the three months ended September 30, 2024. There was no revenue recognized for the same period in 2023. Revenue for the three months ended ...

Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...

The company provides “primate research and development support to the scientific community,” according to its website.